Connect with us

Investing

Oil gains as U.S. fuel stocks drop, OPEC+ considers deal rollover

Published

on

Oil gains as U.S. fuel stocks drop, OPEC+ considers deal rollover 1

By Stephanie Kelly

NEW YORK (Reuters) – Oil prices rose more than 2% on Wednesday, boosted by a huge drop in U.S. fuel inventories and expectations that OPEC+ producers might decide against increasing output when they meet this week.

U.S. gasoline stocks fell last week by the most on record and refining output fell to a record low in the wake of a deep freeze in Texas that shut production.

Gasoline inventories fell to 243.5 million barrels, the U.S. Energy Information Administration said, while distillate stockpiles fell by the most since 2003 to 143 million barrels.

“This drop is 100% based upon the storm in Texas,” said John Kilduff, partner at Again Capital Markets in New York. “It froze up the entire Texas supply chain and caused a drawdown on available refined product stores.”

Crude inventories rose by 21.6 million barrels, the most on record, to 484.6 million barrels, EIA said. Refining capacity use fell to just 56% of overall capacity, the lowest on record, as the U.S. Gulf Coast’s refining capacity use plunged to 40.9%, the lowest ever.

Brent crude rose $1.30, or 2.1%, to $64.00 a barrel, a 2.1 percent gain by 11:11 a.m. EST (1611 GMT). U.S. West Texas Intermediate (WTI) crude rose $1.55, or 2.6%, to $61.30 a barrel.

Oil prices earlier jumped after Reuters, citing three sources, reported that the OPEC+ group comprising the Organization of the Petroleum Exporting Countries and allies including Russia is considering rolling over production cuts from March into April rather than raising output.

The group had previously been widely expected to ease the production cuts when it meets on Thursday.

Kuwaiti Oil Minister Mohammad al-Fares said the market was being supported by optimism over vaccinations.

Also positive for prices, U.S. President Joe Biden said the United States would have enough COVID-19 vaccines for every American adult by the end of May after Merck & Co agreed to make rival Johnson & Johnson’s inoculation.

Biden said he hoped that the United States would be “back to normal” at this time next year and potentially sooner.

(Reporting by Stephanie Kelly in New York; additional reporting by Bozorgmehr Sharafedin in London and Shu Zhang and Sonali Paul in Singapore; Editing by Edmund Blair and David Goodman)

 

Editorial & Advertiser disclosure

Call For Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now

Newsletters with Secrets & Analysis. Subscribe Now

Newsletters with Secrets & Analysis. Subscribe Now